Post-effective amendment to a registration statement that is not immediately effective upon filing

Condensed Consolidated Balance Sheets

v2.4.0.6
Condensed Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2011
Dec. 31, 2010
Dec. 31, 2009
Assets      
Cash and cash equivalents $ 2,772 $ 3,180 $ 3,300
Receivables 2,797 1,225 66
Prepaid expenses and other current assets 899 294 250
Total current assets 6,468 4,699 3,616
Property and equipment, net 83 53 110
Total assets 6,551 4,752 3,726
Liabilities and Stockholders' Deficit      
Accounts payable 3,026 2,457 335
Accrued expenses 1,357 705 123
Other accrued liabilities   373 564
Current portion of long-term debt 2,000 1,870 525
Total current liabilities 6,383 5,405 1,547
Warrant liability 4,713    
Long-term debt, net of discount 13,005 5,400 2,386
Total liabilities 24,101 10,805 3,933
Commitments and contingencies (Note 5)        
Stockholders' deficit:      
Common stock, at amounts paid-in 256,436 256,436 256,436
Additional paid-in capital 18,064 17,256 15,027
Accumulated deficit (292,050) (279,745) (272,911)
Total Titan pharmaceuticals incs stockholders deficits (17,550) (6,053) (1,448)
Non-controlling interest     1,241
Total stockholders' deficit   (6,053) (207)
Total liabilities and stockholders' deficit $ 6,551 $ 4,752 $ 3,726